No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Which Subsectors to Own and Which to Avoid – Wolfe Research
BRC-002 Receives Orphan Drug Designation From FDA for Complex Regional Pain Syndrome
Analysts Have Been Trimming Their BRC Inc. (NYSE:BRCC) Price Target After Its Latest Report
Roth MKM Reiterates Neutral on BRC, Lowers Price Target to $3.5
BRC Analyst Ratings
Express News | BRC Inc : Truist Securities Cuts Target Price to $4 From $5